SDC1 is a critical transmembrane proteoglycan in breast cancer

Abstract There has been an increasing incidence of breast cancer around the world in recent years. As a burgeoning model of diagnosis and treatment, precision medicine has become a new trend in breast cancer management. Dysregulated glycometabolism is well established as a tumor feature. SDC1 is a g...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingying Mei, Lantao Zhao, Na Zhou
Format: Article
Language:English
Published: BMC 2025-05-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-025-03840-z
Tags: Add Tag
No Tags, Be the first to tag this record!